cancer
The Genes Behind Colorectal Cancer Relapse
Researchers are developing a diagnostic test for metasizing colon cancer based on the patient's genetic profile.
One-Two Punch Knocks Out Cancer Cells
Blocking the enzyme CK1α can disrupt cellular digestion processes in RAS-driven cancers, scientists say.
Asian Patients Should Get Lower Dose Of Kidney Cancer Drug
Singaporean mRCC patients could see a 30 percent reduction in their drug fees thanks to a lower dosing regiment.
Innovent & Lilly Announce US$456 Million Cancer Drug Deal
Innovent and Lilly form a broad alliance to develop at least three cancer drugs over the next decade.
The One-Two Punch Of DNA Damage & Repair Inhibition
Scientists have found a drug that not only causes DNA damage but also prevents repair, enhancing its potency in treating cancer.
Eisai & Merck To Test Combination Cancer Drugs
Eisai and Merck have entered a partnership to test combinations of their patented drugs on breast and other cancers.
Stopping Inflammation-Related Cancers
Rather than inhibiting the expression of FAT-10, simply blocking its binding to MAD2 could help prevent tumor progression.
Enabling Patient-Specific Cancer Predictions
OncoIMPACT can make sense of highly complex omics data, using them to produce personalized cancer predictions.
We Don’t Need No (Science) Education
When the media gets it wrong, there can be serious repercussions on the health decisions of the man on the street.
